The results of BRD4 protein degradation mediated by SPOP mutation in the two cancers are different, and the specific mechanism is not clear, but these findings emphasize that the accumulation of BRD4 protein is the key determinant of the development of BETi resistance as well as a condition for tumor development (41–43). Here, SPOP is linked to neoplasm.